Because certain IPF and post-transplant medications can cause sun sensitivity, skin protection is crucial, says columnist Sam Kirton.

A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary ...

Clinical trials are an important part of IPF research, says columnist Sam Kirton, but we need people willing to participate in them.

Over the coming months, the Pulmonary Fibrosis Foundation's 2025 PFF Walk will aim to raise more than $1 million for the ...

In total, 165 IPF patients with chronic cough were randomly assigned to one of three doses of nalbuphine ER (27, 54, or 108 mg) or a placebo, twice daily. The primary goal was to assess the therapy’s ...

“Following productive FDA interactions and positive top-line results from the Phase 1b trial, we have designed our RENEW trial to test the promise of our dual mechanism approach to targeting alveolar ...

Developer to now seek orphan drug status for tranilast in US Orphan drug designation is granted by the European Commission to medications that target serious diseases affecting no more than 5 in ...

To find out, a research team led by Victor Thannickal, MD, senior study author and professor of medicine at Tulane, examined gene activity and protein production in lung tissues from IPF patients. The ...

Inflammation and immune activation are known features of IPF. Previous research has shown that IPF patients exhibit elevated antibody levels in the lungs — which could contribute to tissue damage. But ...